Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EG-70 |
Trade Name | |
Synonyms | EG 70|EG70|Detalimogene voraplasmid |
Drug Descriptions |
EG-70 consists of a DNA vector engineered to express interleukin-12 (IL-12) and a retinoic acid-inducible gene I protein (RIG-I; DDX58) activator in a nanoparticle-based formulation, which leads to increased levels of IL-12, and potentially results in activation of an antitumor immune response (Urologic Oncology, 42, Supplement, 2024, S48). |
DrugClasses | |
CAS Registry Number | 2660044-23-3 |
NCIT ID | C179685 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EG-70 | EG-70 | 0 | 1 |